Meta AnalysisID 7904

芝麻素对肥胖相关疾病动物模型的影响:一项系统评价和Meta分析

CRD42023438502

Does sesamin have an effect on animal models of obesity-associated diseases? Context and rationale Obesity is a major risk factor for several diseases, including metabolic syndrome (MetS), non-alcoholic fatty liver disea

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
7904
Evidence Id
16462
Core Evidence Id
16462
Source Meta Analysis Id
7899
Herb2 Meta Analysis Id
HBMA007899
Crd Id
CRD42023438502
Title
Effects of Sesamin in animal models of obesity-associated diseases: Asystematic review and meta-analysis
Review Question
Does sesamin have an effect on animal models of obesity-associated diseases? Context and rationale Obesity is a major risk factor for several diseases, including metabolic syndrome (MetS), non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D). The use of natural products, such as Sesamin, the main lignin constituent of sesame, plays a pivotal role in regulating physical state. pluvialis, has gained particular interest to reduce oxidative stress and inflammation, and to improve redox status, often associated with obesity. A systematic review and meta-analysis was performed to comprehensively examine the effects of sesamin in animal models of diet induced obesity-associated diseases in order to inform the design of future human clinical studies for sesamin use as supplement or nutraceutical.
Study Type Included
Inclusion criteria: controlled studies with a separate control group Exclusion criteria: case studies, cross-over studies, studies without a separate control group
Condition Being Studied
Participant
Animal
Inclusion criteria: All rodents with obesity diseases such as metabolic syndrome, type 2 diabetes and nonalcoholic fatty liver, all sexes and all ages Exclusion criteria: (i)animals that are not rodents;(ii)T1D;(iii)In vitro research
Human Disease Modelled
Non-human animal models of obesity-associated diseases
Intervention
Inclusion criteria: sesamin (>90% purity) via daily oral to produce a therapeutic effect on diabetes mellitus 2, metabolic syndrome and Non alcoholic fatty liver disease. Exclusion criteria: (i)sesamin were studied in combination with other drugs;(ii)sesamin are less than 90% pure
Comparator Control
Inclusion criteria: Animal models of obesity-associated diseases induced treated with vehicle / placebo, or standard treatment and healthy animal control. Exclusion criteria: Animal models treated with any other drug, experiments without control group.
Main Outcome
Outcome Measure
Inclusion criteria: We will evaluate the efficacy of sesamin on Blood glucose levels, insulin levels TC TG AST ALT SOD Iiver weight SBP CAT GPX4 AKT GSK-3 TNF-α IL-6 MDA and body weight in diabetic rodents Exclusion criteria: Measurements of parameters other than those cited above.
Additional Outcome
Study Method
Keyword
Animals; Biological Products; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Inflammation; Lignin; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Oxidation-Reduction; Oxidative Stress; Risk Factors; Sesamum; sesamin
Contact
ZUO JINSHI [email protected]
Organisational Affiliation
河北医科大学 https://www.hebmu.edu.cn
Funding Source
National Natural Science Foundation of China Grant number(s) No. 81874264
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Experimental animal exposure review
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2023-06-27
Registration Date
2023-07-12
Anticipated Start Date
2023-05-30
Anticipated Completion Date
2023-08-07
Title Cn
芝麻素对肥胖相关疾病动物模型的影响:一项系统评价和Meta分析
Title En
Effects of Sesamin in animal models of obesity-associated diseases: Asystematic review and meta-analysis
Bilingual Status
complete